Biologicals — Net Sales
Corteva Biologicals — Net Sales increased by 51.5% to $147.00M in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 8.9%, from $135.00M to $147.00M. Over 2 years (FY 2022 to FY 2024), Biologicals — Net Sales shows an upward trend with a 174.9% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
How to read this metric
An increase indicates successful market adoption of sustainable agricultural solutions and effective expansion of the company's high-growth product portfolio. A decrease may signal competitive pressure in the biologicals space or slower-than-expected transition from traditional chemical inputs.
Detailed definition
This metric represents the total revenue generated from the sale of biological agricultural products, including biostimu...
Peer comparison
Peers in the agricultural inputs sector report this under various labels such as 'Bio-solutions' or 'Sustainable Agriculture,' with investors looking for double-digit growth rates as these products represent the future of sustainable farming.
ctva_segment_biologicals_net_salesHistorical Data
| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $15.75M | $15.75M | $15.75M | $15.75M | $122.75M | $122.75M | $122.75M | $122.75M | $82.00M | $90.00M | $135.00M | $169.00M | $84.00M | $97.00M | $147.00M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +679.4% | +0.0% | +0.0% | +0.0% | -33.2% | +9.8% | +50.0% | +25.2% | -50.3% | +15.5% | +51.5% |
| YoY Change | — | — | — | — | +679.4% | +679.4% | +679.4% | +679.4% | -33.2% | -26.7% | +10.0% | +37.7% | +2.4% | +7.8% | +8.9% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Corteva's biologicals — net sales?
- Corteva (CTVA) reported biologicals — net sales of $147.00M in Q3 2025.
- How has Corteva's biologicals — net sales changed year-over-year?
- Corteva's biologicals — net sales increased by 8.9% year-over-year, from $135.00M to $147.00M.
- What is the long-term trend for Corteva's biologicals — net sales?
- Over 2 years (2022 to 2024), Corteva's biologicals — net sales has grown at a 174.9% compound annual growth rate (CAGR), from $63.00M to $476.00M.
- What does biologicals — net sales mean?
- The total revenue earned from selling biological-based crop protection and enhancement products.